Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P McConnell

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|July 25, 2008
Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?Amir Lerman, Joseph P McConnell
Clinics in Laboratory Medicine|August 30, 2006
Lipoprotein-associated phospholipase A2Joseph P McConnell, Daniel M Hoefner
Clinical Chemistry|April 30, 2008
Variability of lipoprotein-associated phospholipase A2 measurementsJoseph P McConnell, Allan S Jaffe
Clinical Chemistry|December 3, 2008
The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial?Joseph P McConnell, Allan S Jaffe
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2016
Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United StatesSteve Varvel, Joseph P McConnell, Sotirios Tsimikas
Clinical Laboratory Science : Journal of the American Society for Medical Technology|December 9, 2009
Hypovitaminosis D: a new risk marker for cardiovascular diseaseJoseph P McConnell, Kevin F Foley, Gina M Vargas
Clinical Chemistry|December 2, 2008
Concerns regarding lipoprotein particle measurement by ion mobility analysisJames D Otvos, Lawrence L Rudel, Joseph P McConnell
Current Vascular Pharmacology|February 3, 2007
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus riskVirginia M Miller, Margaret M Redfield, Joseph P McConnell
Molecular Diagnosis & Therapy|August 21, 2007
Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunctionShahar Lavi, Ronit Lavi, Joseph P McConnell, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 2008
Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetryNichole L Korpi-Steiner, Jennie N Ward, Vivek Kumar, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|July 25, 2008
Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?Amir Lerman, Joseph P McConnell
Clinics in Laboratory Medicine|August 30, 2006
Lipoprotein-associated phospholipase A2Joseph P McConnell, Daniel M Hoefner
Clinical Chemistry|April 30, 2008
Variability of lipoprotein-associated phospholipase A2 measurementsJoseph P McConnell, Allan S Jaffe
Clinical Chemistry|December 3, 2008
The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial?Joseph P McConnell, Allan S Jaffe
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2016
Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United StatesSteve Varvel, Joseph P McConnell, Sotirios Tsimikas
Clinical Laboratory Science : Journal of the American Society for Medical Technology|December 9, 2009
Hypovitaminosis D: a new risk marker for cardiovascular diseaseJoseph P McConnell, Kevin F Foley, Gina M Vargas
Clinical Chemistry|December 2, 2008
Concerns regarding lipoprotein particle measurement by ion mobility analysisJames D Otvos, Lawrence L Rudel, Joseph P McConnell
Current Vascular Pharmacology|February 3, 2007
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus riskVirginia M Miller, Margaret M Redfield, Joseph P McConnell
Molecular Diagnosis & Therapy|August 21, 2007
Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunctionShahar Lavi, Ronit Lavi, Joseph P McConnell, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 30, 2008
Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetryNichole L Korpi-Steiner, Jennie N Ward, Vivek Kumar, et al.
Pageof 9